• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Stock

FDA officially authorizes Zyn nicotine pouches for sale following health review

by January 17, 2025
written by January 17, 2025

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an ‘extensive scientific review’ about their safety.

In a release Thursday, the agency said it had found that the popular pouches posed lower risk of cancer and other serious health conditions compared with cigarettes, as well as in relation to other smokeless tobacco products.

The agency also found that the pouches even had the potential to benefit cigarette smokers amid evidence that they can get them to quit.

‘The data show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products,” Matthew Farrelly, director of the office of science in the FDA’s Center for Tobacco Products, said in a statement. 

Zyn use has exploded in recent years in the wake of a viral online meme trend, even prompting a shortage last year. Yet the product had been operating in a legal gray area while it underwent official FDA review about its health effects and uptake among young users.

To that latter point, the FDA found that, so far, Zyn use among youths appeared to be relatively low, though it was continuing to monitor the trend.

A spokesperson for Philip Morris International Inc., which owns the U.S. rights to Zyn, did not immediately respond to a request for comment.

Swedish Match, the developer of Zyn, said in a statement, “The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.”

The Campaign for Tobacco-Free Kids slammed the FDA’s decision in a separate statement.

‘The FDA today has set a dangerous precedent that puts the nation’s kids at risk by authorizing the sale of 20 Zyn nicotine pouch products with flavors that clearly appeal to kids, including chill, citrus, cool mint and peppermint,’ it said.

‘The FDA’s decision is deeply troubling given the extensive scientific evidence that flavored tobacco products appeal to kids and the fact that nicotine pouches were the only category of tobacco product that saw an increase in youth use last year. The FDA is sanctioning a flavored tobacco product that is already increasing in popularity with kids and repeating the mistakes it made with Juul that resulted in the youth e-cigarette epidemic.’

In the release, the FDA emphasized that its findings about Zyn did not mean the products are ultimately safe or “FDA approved.”

‘There is no safe tobacco product,’ the agency said. ‘Youth should not use tobacco products and adults who do not use tobacco products should not start.’

This post appeared first on NBC NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
RNC chair Whatley vows to be ‘tip of the spear’ to protect Trump after coasting to reelection victory
next post
Vanguard fined more than $100 million by SEC over violations involving target date retirement funds

related articles

Dick’s Sporting Goods stands by full-year guidance —...

May 28, 2025

Macy’s CEO says retailer will hike some prices...

May 28, 2025

23andMe to delist from Nasdaq, deregister with SEC

May 28, 2025

Walmart fined for shipping realistic toy guns to...

May 28, 2025

Why Trump’s iPhone tariff threat might not be...

May 25, 2025

United Airlines reaches ‘industry-leading’ labor deal with flight...

May 24, 2025

Trump clears Nippon merger with U.S. Steel

May 24, 2025

FTC drops Biden-era suit accusing Pepsi of price...

May 23, 2025

How UnitedHealthcare became the face of America’s health...

May 22, 2025

Burger King targets families through movie partnerships in...

May 22, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Former Hamas hostage details horrors of captivity, credits kidnapped IDF soldier with saving her life

    January 29, 2025
  • Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 30, 2024
  • Trump seizes on drone controversy to mock Chris Christie

    December 15, 2024
  • Zelenskyy says ire with Trump began with pro-Putin rhetoric

    March 1, 2025
  • AOC chimes in after JD Vance refers to Kamala Harris as ‘trash’

    November 5, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (4,691)
  • Investing (624)
  • Stock (770)

Latest Posts

  • Dollar index in anticipation of NFP and unemployment report

    September 6, 2024
  • Voting on Election Day: Here’s when polls close for all 50 states

    November 5, 2024
  • EURUSD and GBPUSD: Pound tries to release pressure at 1.2800

    August 5, 2024

Recent Posts

  • Fox News voter panel says Harris won debate

    September 11, 2024
  • Walz unknown by 4 in 10 Americans, but favorability rating tops Vance: poll

    August 21, 2024
  • 23andMe bankruptcy prompts Cornyn-Grassley-Klobuchar bipartisan bill to protect sensitive genetic data

    May 22, 2025

Editor’s Pick

  • Ethereum price is close to forming a new weekly high

    August 23, 2024
  • Fetterman would be willing to confirm Dr. Oz — on one condition

    November 20, 2024
  • Trump taps Richard Grenell as presidential envoy for special missions, Edward S. Walsh as Ireland ambassador

    December 15, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock